Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 61 clinical trials
None
Clinico-biological Data Collection Study of Metastatic Breast Cancer

RATIONALE : Currently, the mechanisms associated with the response or resistance to treatment are poorly understood and are multifactorial. These mechanisms involve clinical and biological factors associated with the host and the tumor and possibly the patient's psycho-social environment. PURPOSE : This trial will assess the use of a prospective …

progesterone
adjuvant therapy
metastasis
immunostimulant
HER2
  • 1 views
  • 29 Jun, 2021
  • 2 locations
None
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

With the aging of society, the incidence of elderly leukemia in China has been increasing year by year. The elderly patients with Acute Leukemia have poor basal state, and there are many important organ diseases such as heart, liver and kidney. The incidence of infection and hemorrhage is high in …

colony stimulating factor
decitabine
cancer
acute leukemia
cytarabine
  • 0 views
  • 23 Jan, 2021
  • 1 location
None
AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR)Trial

Researchers are comparing two drug therapy plans to treat heart function changes after anthracycline-based treatment for lymphoma.

  • 0 views
  • 16 May, 2021
  • 1 location
None
Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer

The efficacy and safety of immunotherapy and antiangiotherapy in combination with chemotherapy in neoadjuvant therapy for triple-negative breast cancer (TNBC) were determined by the addition of sintilimab and apatinib to neoadjuvant chemotherapy To clarify the breast-conserving rate, toxicity, difference in pathologic complete response (pCR) rate of patients with PD-L1 (+) …

epidermal growth factor receptor
estrogen receptor
progesterone
measurable disease
carboplatin
  • 0 views
  • 19 May, 2021
  • 1 location
None
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study

Anthracycline (AC) chemotherapy has substantially reduced the mortality rate from several common cancers globally. Unfortunately, AC treatment is associated with up to 19% risk of heart failure (HF). Current standard of care for preventing AC induced HF (AIHF) is cardiac surveillance followed by initiation of treatment once HF is diagnosed. …

anthracyclines
diabetes
stenosis
hypertension
sarcoma
  • 8 views
  • 21 Aug, 2021
  • 1 location
None
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

This phase II trial studies how well nab-paclitaxel and alpelisib works in treating patients with triple negative breast cancer with PIK3CA or PTEN alterations that does not respond to anthracycline chemotherapy (anthrocycline refractory). Drugs used in chemotherapy, such as nab-paclitaxel, work in different ways to stop the growth of tumor …

anthracyclines
progesterone
diabetes
hba1c
fasting
  • 0 views
  • 24 Jan, 2021
  • 1 location
None
French Childhood Cancer Survivor Study

The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years. The study is concerned by improving knowledge about the long-term effects caused by cancer and its treatments including adverse health and social …

  • 3 views
  • 08 Nov, 2020
None
Tissue Doppler Assessment of Right Ventricle Function in Pediatrics Underwent Chemotherapy

Tissue Doppler assessment of right ventricular function in newly diagnosed pediatric cancer patients underwent chemotherapy in South Egypt Cancer Institute.

  • 0 views
  • 15 Apr, 2021
  • 1 location
None
Evaluation of the Relationship of TOP2 Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

, including 400 patients received the anthracyclines followed taxanes chemotherapy, and the other 400 patients who have received regiments containing no taxanes. Three tumor tissue slices of all the enrolled

anthracyclines
ki-67
taxane
aromatase inhibitor
invasive breast cancer
  • 0 views
  • 21 Jan, 2021
  • 1 location
None
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer

combined with radiotherapy (RT), anthracyclines, aromatase inhibitors and/or trastuzumab (Herceptin) which all have improved the life expectancy and survival in breast cancer patients.

anthracyclines
hypercholesterolemia
cancer
herceptin
aromatase inhibitor
  • 0 views
  • 27 Jan, 2021
  • 4 locations